沃森生物

- 300142

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015  2014 
沃森生物(300142) 利润表
单位:万元
报表日期2024-09-302024-06-302024-03-312023-12-312023-09-30
一、营业总收入214,134.62143,334.8659,975.36411,377.23315,804.44
营业收入214,134.62143,334.8659,975.36411,377.23315,804.44
二、营业总成本175,603.15117,865.5646,214.98315,221.33232,086.84
营业成本44,062.4328,672.8311,351.8859,755.6245,126.36
营业税金及附加1,373.81934.38417.343,202.602,537.27
销售费用68,070.0850,021.8021,045.57151,957.55114,335.24
管理费用21,991.3112,316.846,178.5629,762.3718,062.65
财务费用-3,005.02-2,776.53-1,480.44-7,099.33-5,318.92
研发费用43,110.5428,696.258,702.0677,642.5357,344.23
资产减值损失----------
公允价值变动收益-9,369.01-10,200.98-8,481.79-23,475.01-6,738.89
投资收益489.69365.448.68711.45629.46
其中:对联营企业和合营企业的投资收益7.480.138.6838.21-43.78
汇兑收益----------
三、营业利润28,608.3018,841.675,964.9261,396.6177,931.16
加:营业外收入12,692.4112,692.410.0193.5193.32
减:营业外支出3,921.793,764.75239.601,592.47602.38
其中:非流动资产处置损失----------
四、利润总额37,378.9227,769.325,725.3259,897.6577,422.11
减:所得税费用2,314.832,017.711,894.108,765.147,699.17
五、净利润35,064.0925,751.613,831.2251,132.5169,722.94
归属于母公司所有者的净利润25,635.8617,056.051,412.7541,939.0255,337.65
少数股东损益9,428.238,695.572,418.479,193.4914,385.29
六、每股收益
基本每股收益(元/股)0.16030.10660.00880.26210.3458
稀释每股收益(元/股)0.16030.10660.00880.26210.3458
七、其他综合收益----------
八、综合收益总额35,064.0925,751.613,831.2251,132.5169,722.94
归属于母公司所有者的综合收益总额25,635.8617,056.051,412.7541,939.0255,337.65
归属于少数股东的综合收益总额9,428.238,695.572,418.479,193.4914,385.29
下载全部历史数据到excel中 返回页顶